[[{“type”:“media”,“view_mode”:“media_large”,“fid”:null,“attributes”:{“class”:“media-image alignright size-full wp-image-1611”,“typeof”:“foaf:Image”,“style”:“”,“width”:“100”,“height”:“100”,“alt”:“USA Today”}}]]USA Today calls a recent recommendation by the U.S. Preventive Services Task Force “part of a broader trend that’s been building for years.”

The government advisory panel’s advice that doctors stop using the PSA test to screen healthy men for prostate cancer fits with an awareness that “overtesting” and “overtreating” patients can put them at risk.

In discussing the growing concern with the implications of “overtreatment,” USA Today turned to three Geisel School of Medicine at Dartmouth experts: Professor Steven Woloshin; Professor H. Gilbert Welch, author of Overdiagnosed: Making People Sick in the Pursuit of Health; and Professor Lisa Schwartz. All three are affiliated with the Dartmouth Institute for Health Policy and Clinical Practice.

Read the full story, published 5/26/12 by USA Today.